196 related articles for article (PubMed ID: 21871019)
1. Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine.
Moore EL; Salvatore CA
Br J Pharmacol; 2012 May; 166(1):66-78. PubMed ID: 21871019
[TBL] [Abstract][Full Text] [Related]
2. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
[TBL] [Abstract][Full Text] [Related]
3. CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
Walker CS; Hay DL
Br J Pharmacol; 2013 Dec; 170(7):1293-307. PubMed ID: 23425327
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene-related peptide responsive receptors.
Garelja ML; Alexander TI; Bennie A; Nimick M; Petersen J; Walker CS; Hay DL
Br J Pharmacol; 2024 Jan; 181(1):142-161. PubMed ID: 37580864
[TBL] [Abstract][Full Text] [Related]
5. Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP and Gs Protein.
Cao J; Belousoff MJ; Danev R; Christopoulos A; Wootten D; Sexton PM
Biochemistry; 2024 May; 63(9):1089-1096. PubMed ID: 38603770
[TBL] [Abstract][Full Text] [Related]
6. Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice.
De Logu F; Nassini R; Hegron A; Landini L; Jensen DD; Latorre R; Ding J; Marini M; Souza Monteiro de Araujo D; Ramírez-Garcia P; Whittaker M; Retamal J; Titiz M; Innocenti A; Davis TP; Veldhuis N; Schmidt BL; Bunnett NW; Geppetti P
Nat Commun; 2022 Feb; 13(1):646. PubMed ID: 35115501
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships for α-calcitonin gene-related peptide.
Watkins HA; Rathbone DL; Barwell J; Hay DL; Poyner DR
Br J Pharmacol; 2013 Dec; 170(7):1308-22. PubMed ID: 23186257
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin Related Polypeptide Alpha Mediates Oral Cancer Pain.
Tu NH; Inoue K; Lewis PK; Khan A; Hwang JH; Chokshi V; Dabovic BB; Selvaraj S; Bhattacharya A; Dubeykovskaya Z; Pinkerton NM; Bunnett NW; Loomis CA; Albertson DG; Schmidt BL
Cells; 2023 Jun; 12(13):. PubMed ID: 37443709
[TBL] [Abstract][Full Text] [Related]
9. Novel peptide calcitonin gene-related peptide antagonists for migraine therapy.
Killoran PM; Capel V; D'Aloisio V; Schofield A; Aczél T; Bölcskei K; Helyes Z; von Mentzer B; Kendall DA; Coxon CR; Hutcheon GA
J Pharm Pharmacol; 2023 Dec; 75(12):1581-1589. PubMed ID: 37742055
[TBL] [Abstract][Full Text] [Related]
10. CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond.
Russo AF; Hay DL
Physiol Rev; 2023 Apr; 103(2):1565-1644. PubMed ID: 36454715
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide: physiology and pathophysiology.
Russell FA; King R; Smillie SJ; Kodji X; Brain SD
Physiol Rev; 2014 Oct; 94(4):1099-142. PubMed ID: 25287861
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in the expression of calcitonin gene-related peptide receptor components in the spinal trigeminal nucleus.
Ji Y; Rizk A; Voulalas P; Aljohani H; Akerman S; Dussor G; Keller A; Masri R
Neurobiol Pain; 2019; 6():100031. PubMed ID: 31223141
[TBL] [Abstract][Full Text] [Related]
13. CGRP Receptor Antagonism in COVID-19: Potential Cardiopulmonary Adverse Effects.
Skaria T; Wälchli T; Vogel J
Trends Mol Med; 2021 Jan; 27(1):7-10. PubMed ID: 33129692
[TBL] [Abstract][Full Text] [Related]
14. Functional Analysis and Tissue-Specific Expression of Calcitonin and CGRP with RAMP-Modulated Receptors CTR and CLR in Chickens.
Huang T; Su J; Wang X; Shi N; Zhang X; He J; Li J; Zhang J; Wang Y
Animals (Basel); 2024 Mar; 14(7):. PubMed ID: 38612299
[TBL] [Abstract][Full Text] [Related]
15. Exploring Ligand Binding to Calcitonin Gene-Related Peptide Receptors.
Deganutti G; Atanasio S; Rujan RM; Sexton PM; Wootten D; Reynolds CA
Front Mol Biosci; 2021; 8():720561. PubMed ID: 34513925
[TBL] [Abstract][Full Text] [Related]
16. Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein-Ligand Complexes.
Cansfield AD; Ator MA; Banerjee J; Bestwick M; Bortolato A; Brown GA; Brown J; Butkovic K; Cansfield JE; Christopher JA; Congreve M; Cseke G; Deflorian F; Dugan B; Hunjadi MP; Hutinec A; Inturi TK; Landek G; Mason J; O'Brien A; Ott GR; Rupcic R; Saxty G; Southall SM; Zadravec R; Watson SP
ACS Chem Neurosci; 2022 Mar; 13(6):751-765. PubMed ID: 35245037
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the structure of RAMP1 by mutagenesis and molecular modeling.
Simms J; Hay DL; Wheatley M; Poyner DR
Biophys J; 2006 Jul; 91(2):662-9. PubMed ID: 16632510
[TBL] [Abstract][Full Text] [Related]
18. Human RAMP1 overexpressing mice are resistant to migraine therapies for motion sensitivity: a mouse model of vestibular migraine.
Rahman SM; Guo L; Minarovich C; Moon L; Guo A; Luebke AE
bioRxiv; 2023 Nov; ():. PubMed ID: 37961568
[TBL] [Abstract][Full Text] [Related]
19. Novel Macrocyclic Antagonists of the CGRP Receptor Part 2: Stereochemical Inversion Induces an Unprecedented Binding Mode.
Southall SM; Banerjee J; Brown J; Butkovic K; Cansfield AD; Cansfield JE; Congreve MS; Cseke G; Deflorian F; Hunjadi MP; Hutinec A; Inturi TK; Rupcic R; Saxty G; Watson SP
ACS Med Chem Lett; 2022 Nov; 13(11):1776-1782. PubMed ID: 36385934
[TBL] [Abstract][Full Text] [Related]
20. Patient Sex in Prescribing CGRP Receptor Antagonists for Migraine-Reply.
Porreca F; Dodick DW
JAMA Neurol; 2024 Feb; ():. PubMed ID: 38407903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
